The estimated Net Worth of Eric Salzman is at least $1.74 Million dollars as of 1 June 2024. Mr Salzman owns over 9,785 units of Safeguard Scientifics stock worth over $7,700 and over the last 13 years he sold SFE stock worth over $1,189,500. In addition, he makes $543,454 as Chief Exec. Officer at Safeguard Scientifics.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mr Salzman SFE stock SEC Form 4 insiders trading
Mr has made over 27 trades of the Safeguard Scientifics stock since 2015, according to the Form 4 filled with the SEC. Most recently he exercised 9,785 units of SFE stock worth $4,501 on 1 June 2024.
The largest trade he's ever made was selling 100,000 units of Safeguard Scientifics stock on 1 November 2022 worth over $419,000. On average, Mr trades about 4,787 units every 35 days since 2012. As of 1 June 2024 he still owns at least 16,739 units of Safeguard Scientifics stock.
You can see the complete history of Mr Salzman stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mr. Eric C. Salzman biography
Eric C. Salzman is the Chief Exec. Officer at Safeguard Scientifics.
What is the salary of Mr Salzman?
As the Chief Exec. Officer of Safeguard Scientifics, the total compensation of Mr Salzman at Safeguard Scientifics is $543,454. There are no executives at Safeguard Scientifics getting paid more.
How old is Mr Salzman?
Mr Salzman is 54, he's been the Chief Exec. Officer of Safeguard Scientifics since . There are 4 older and 3 younger executives at Safeguard Scientifics. The oldest executive at Safeguard Scientifics, Inc. is Dr. Gary J. Kurtzman M.D., 66, who is the Sr. Advisor.
What's Mr Salzman's mailing address?
Eric's mailing address filed with the SEC is , C/O LEONARDO DRS, INC., ARLINGTON, VA, 22202.
Insiders trading at Safeguard Scientifics
Over the last 21 years, insiders at Safeguard Scientifics have traded over $372,519 worth of Safeguard Scientifics stock and bought 877,847 units worth $3,711,567 . The most active insiders traders include Stephen Fisher, Thomas A Jr Satterfield und Michael F Cola. On average, Safeguard Scientifics executives and independent directors trade stock every 51 days with the average trade being worth of $7,022. The most recent stock trade was executed by Thomas A Jr Satterfield on 17 August 2023, trading 294,000 units of SFE stock currently worth $346,920.
What does Safeguard Scientifics do?
safeguard scientifics (nyse:sfe) provides capital and relevant expertise to fuel the growth of technology-driven businesses in healthcare, financial services and digital media. safeguard targets companies that are capitalizing on the next wave of enabling technologies with a particular focus on the internet of everything, enhanced security and artificial intelligence, which includes predictive analytics and machine learning. safeguard typically deploys between $5 million and $25 million over the course of its partnership with a company, initially investing in a series a or b round and opportunistically in a seed round. safeguard has a distinguished track record of fostering innovation and building market leaders that spans more than six decades.
What does Safeguard Scientifics's logo look like?
Complete history of Mr Salzman stock trades at 8x8 Inc, Safeguard Scientifics, 8X8 und Leonardo DRS
Safeguard Scientifics executives and stock owners
Safeguard Scientifics executives and other stock owners filed with the SEC include:
-
Eric C. Salzman,
Chief Exec. Officer -
Mark A. Herndon CPA,
Sr. VP & CFO -
Mark Herndon,
Chief Financial Officer, Senior Vice President -
Robert Rosenthal,
Executive Chairman of the Board, Principal Executive Officer -
Maureen Morrison,
Independent Director -
Russell Glass,
Independent Director -
Joseph Manko,
Independent Director -
Eric Salzman,
Chief Restructuring Officer -
Seth Zuckerman,
Sr. Associate of Healthcare -
Alex A. Fuiks,
Associate -
Steven J. Grenfell CPA, CPA,
Sr. Advisor -
Dr. Gary J. Kurtzman M.D.,
Sr. Advisor -
G. Matthew Barnard,
Gen. Counsel, Sec. & Compliance Officer -
David A Kille,
Senior VP & CFO -
Brian J Sisko,
President & CEO -
Bob Rosenthal,
Director -
Jeffrey Brian Mc Groarty,
Senior VP - Finance -
Stephen T Zarrilli,
Acting Sr VP & Acting CFO -
Julie A Dobson,
Director -
John Joseph Roberts,
Director -
George Mackenzie,
Director -
Stephen Fisher,
Director -
Beth Michelson,
Director -
Ross D De Mont,
Director -
Ira M Lubert,
Director -
Thomas A Jr Satterfield,
10% owner -
Keith B Jarrett,
Director -
Peter J Boni,
President & CEO -
Jack L Messman,
Director -
George D Mcclelland,
Director -
James A Datin,
Executive Vice President -
Mara G. Aspinall,
Director -
Kevin L Kemmerer,
Sr. VP & Managing Director -
Michael J Cody,
Director -
Robert Ripp,
Director -
Anthony L Craig,
President & CEO -
Christopher J Davis,
Managing Director and CFO -
John William Sr Poduska,
Director -
Steven J Feder,
Sr. V.P. & General Counsel -
Robert E Jr Keith,
Director -
Michael F Cola,
Managing Director -
Raymond J Land,
Senior V.P. & CFO -
John A Loftus,
Sr. Vice President & CTO -
Anthony Ibarguen,
Managing Director -
Russell E Palmer,
Director